跳至主要内容
临床试验/NCT05520281
NCT05520281已完成不适用

ORPHYS - Short-term Psychodynamic Psychotherapy in Serious Physical Illness

Universitätsklinikum Hamburg-Eppendorf8 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2022年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
8
主要终点
Treatment feasibility

研究概览

简要总结

Life-threatening physical illness may powerfully re-activate existential conflict. There is little evidence to date on the effectiveness of relationship-focused therapies in this patient group.The aim of this study is to pilot a psychodynamic treatment for patients with advanced cancer and high psychological distress.

详细描述

Severely physically ill patients may experience existential distress symptoms including helplessness, hopelessness, death anxiety, perceived burdensomeness and a sense of pointlessness. The latter can significantly interfere with end-of-life care processes and outcomes (receipt of treatment according to preferences, expression of desire for hastened death). So far, empirically tested psychotherapeutic programs in advanced life-threatening illness have predominantly been ultra-short and applied supportive and resource-oriented techniques. Psychodynamic treatment allows to address clinically significant existential distress through its conceptualization from early relational life experiences.

The aim of this study is to pilot a psychodynamic treatment for patients with advanced cancer and high psychological distress.The inverstigators will

  1. analyse the feasibility of the treatment, and
  2. investigate changes in process- and patient-relevant outcomes over the course of the treatment

The inverstigators will conduct a single-group pre-post study with five assessment points in which 50 adult patients diagnosed with advanced cancer will receive a manualized psychodynamic short-term therapy. Target parameters are assessed by diagnostic interviews, focus interviews, self-assessment questionnaires as well as electronic patient records. For research objective b) the investigators will compare the intervention group with a matched comparison group of a longitudinal cohort sample (NCT04600206). Matching will be based on stress level, demographic, and medical parameters across the 5 assessment points.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years and older
  • UICC stage IV solid tumor
  • Informed consent
  • Current physical condition that allows for at least 12 therapy sessions
  • Indication: Presence of a mental disorder with existential stress and limitations in coping capacity

排除标准

  • Acute suicidality
  • Psychotic disorder (ICD-10: F2 diagnosis)
  • Substance dependence or abuse (ICD-10: F1 diagnosis)
  • Structural deficits that interfere with attending to regular appointments
  • Other psychotherapeutic treatment
  • Severe cognitive impairment
  • Severe physical impairment
  • Insufficient German to give informed consent and complete self-report questionnaires

结局指标

主要结局

Treatment feasibility

时间窗: through study completion, an average of 6 months

Will be assessed via semi-structured qualitative interviews.

Treatment adherence

时间窗: through study completion, an average of 6 months

Will be assessed via qualitative analysis of therapeutic session protocols and audio recordings.

Therapeutic competence

时间窗: through study completion, an average of 6 months

Will be assessed via qualitative analysis of supervision protocols.

Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability)

时间窗: up to 12-months follow-up

Will be assessed via Inventory for the Balanced Assessment of Negative Effects of Psychotherapy (INEP, Ladwig, Rief \& Nestoriuc, 2014).

Acceptance

时间窗: through study completion, an average of 6 months

Will be assessed via drop-out rates (number of patients not completing at least 12 sessions) and treatment compliance (number of sessions missed).

次要结局

  • Therapeutic process(through study completion, an average of 6 months)
  • Therapeutic alliance I(3-, 6- 9- and 12-months follow-up)
  • Interpersonal problems(Baseline, 3-, 6-, 9- and 12-months follow up)
  • Therapeutic alliance II(3-, 6- 9- and 12-months follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验